Literature DB >> 24733460

Predictive models for identification of hospitalized patients harboring KPC-producing Klebsiella pneumoniae.

Mario Tumbarello1, Enrico Maria Trecarichi2, Fabio Tumietto3, Valerio Del Bono4, Francesco Giuseppe De Rosa5, Matteo Bassetti6, Angela Raffaella Losito2, Sara Tedeschi3, Carolina Saffioti4, Silvia Corcione5, Maddalena Giannella3, Francesca Raffaelli2, Nicole Pagani5, Michele Bartoletti3, Teresa Spanu7, Anna Marchese8, Roberto Cauda2, Claudio Viscoli4, Pierluigi Viale3.   

Abstract

The production of Klebsiella pneumoniae carbapenemases (KPCs) by Enterobacteriaceae has become a significant problem in recent years. To identify factors that could predict isolation of KPC-producing K. pneumoniae (KPCKP) in clinical samples from hospitalized patients, we conducted a retrospective, matched (1:2) case-control study in five large Italian hospitals. The case cohort consisted of adult inpatients whose hospital stay included at least one documented isolation of a KPCKP strain from a clinical specimen. For each case enrolled, we randomly selected two matched controls with no KPCKP-positive cultures of any type during their hospitalization. Matching involved hospital, ward, and month/year of admission, as well as time at risk for KPCKP isolation. A subgroup analysis was also carried out to identify risk factors specifically associated with true KPCKP infection. During the study period, KPCKP was isolated from clinical samples of 657 patients; 426 of these cases appeared to be true infections. Independent predictors of KPCKP isolation were recent admission to an intensive care unit (ICU), indwelling urinary catheter, central venous catheter (CVC), and/or surgical drain, ≥ 2 recent hospitalizations, hematological cancer, and recent fluoroquinolone and/or carbapenem therapy. A Charlson index of ≥ 3, indwelling CVC, recent surgery, neutropenia, ≥ 2 recent hospitalizations, and recent fluoroquinolone and/or carbapenem therapy were independent risk factors for KPCKP infection. Models developed to predict KPCKP isolation and KPCKP infection displayed good predictive power, with the areas under the receiver-operating characteristic curves of 0.82 (95% confidence interval [CI], 0.80 to 0.84) and 0.82 (95% CI, 0.80 to 0.85), respectively. This study provides novel information which might be useful for the clinical management of patients harboring KPCKP and for controlling the spread of this organism.
Copyright © 2014, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24733460      PMCID: PMC4068482          DOI: 10.1128/AAC.02373-13

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  31 in total

1.  Predictors of mortality in patients with bloodstream infections caused by extended-spectrum-beta-lactamase-producing Enterobacteriaceae: importance of inadequate initial antimicrobial treatment.

Authors:  Mario Tumbarello; Maurizio Sanguinetti; Eva Montuori; Enrico M Trecarichi; Brunella Posteraro; Barbara Fiori; Rita Citton; Tiziana D'Inzeo; Giovanni Fadda; Roberto Cauda; Teresa Spanu
Journal:  Antimicrob Agents Chemother       Date:  2007-03-26       Impact factor: 5.191

2.  Carbapenem-resistant isolates of Klebsiella pneumoniae in China and detection of a conjugative plasmid (blaKPC-2 plus qnrB4) and a blaIMP-4 gene.

Authors:  Rodrigo E Mendes; Jan M Bell; John D Turnidge; Qiwen Yang; Yunsong Yu; Ziyong Sun; Ronald N Jones
Journal:  Antimicrob Agents Chemother       Date:  2007-12-17       Impact factor: 5.191

3.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.

Authors:  M E Charlson; P Pompei; K L Ales; C R MacKenzie
Journal:  J Chronic Dis       Date:  1987

Review 4.  Detection and treatment options for Klebsiella pneumoniae carbapenemases (KPCs): an emerging cause of multidrug-resistant infection.

Authors:  Elizabeth B Hirsch; Vincent H Tam
Journal:  J Antimicrob Chemother       Date:  2010-04-08       Impact factor: 5.790

Review 5.  Predictors of mortality in multidrug-resistant Klebsiella pneumoniae bloodstream infections.

Authors:  Pierluigi Viale; Maddalena Giannella; Russell Lewis; Emanuele Maria Trecarichi; Nicola Petrosillo; Mario Tumbarello
Journal:  Expert Rev Anti Infect Ther       Date:  2013-09-27       Impact factor: 5.091

6.  Carbapenem-non-susceptible Enterobacteriaceae in Europe: conclusions from a meeting of national experts.

Authors:  H Grundmann; D M Livermore; C G Giske; R Canton; G M Rossolini; J Campos; A Vatopoulos; M Gniadkowski; A Toth; Y Pfeifer; V Jarlier; Y Carmeli
Journal:  Euro Surveill       Date:  2010-11-18

7.  Risk factors and clinical impact of Klebsiella pneumoniae carbapenemase-producing K. pneumoniae.

Authors:  Leanne B Gasink; Paul H Edelstein; Ebbing Lautenbach; Marie Synnestvedt; Neil O Fishman
Journal:  Infect Control Hosp Epidemiol       Date:  2009-12       Impact factor: 3.254

8.  Risk factors of carbapenem-resistant Klebsiella pneumoniae infections: a matched case control study.

Authors:  Matthew E Falagas; Petros I Rafailidis; Diamantis Kofteridis; Simona Virtzili; Fotini C Chelvatzoglou; Vassiliki Papaioannou; Sofia Maraki; George Samonis; Argyris Michalopoulos
Journal:  J Antimicrob Chemother       Date:  2007-09-20       Impact factor: 5.790

9.  Outcomes of carbapenem-resistant Klebsiella pneumoniae infection and the impact of antimicrobial and adjunctive therapies.

Authors:  Gopi Patel; Shirish Huprikar; Stephanie H Factor; Stephen G Jenkins; David P Calfee
Journal:  Infect Control Hosp Epidemiol       Date:  2008-12       Impact factor: 3.254

10.  Predictors of carbapenem-resistant Klebsiella pneumoniae acquisition among hospitalized adults and effect of acquisition on mortality.

Authors:  Mitchell J Schwaber; Shiri Klarfeld-Lidji; Shiri Navon-Venezia; David Schwartz; Azita Leavitt; Yehuda Carmeli
Journal:  Antimicrob Agents Chemother       Date:  2007-12-17       Impact factor: 5.191

View more
  18 in total

Review 1.  Bloodstream infections in the Intensive Care Unit.

Authors:  Matteo Bassetti; Elda Righi; Alessia Carnelutti
Journal:  Virulence       Date:  2016-01-13       Impact factor: 5.882

2.  Previous bloodstream infections due to other pathogens as predictors of carbapenem-resistant Klebsiella pneumoniae bacteraemia in colonized patients: results from a retrospective multicentre study.

Authors:  D R Giacobbe; V Del Bono; P Bruzzi; S Corcione; M Giannella; A Marchese; L Magnasco; A E Maraolo; N Pagani; C Saffioti; S Ambretti; C S Cardellino; E Coppo; F G De Rosa; P Viale; C Viscoli
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-12-01       Impact factor: 3.267

3.  Impact of a mixed educational and semi-restrictive antimicrobial stewardship project in a large teaching hospital in Northern Italy.

Authors:  Daniele Roberto Giacobbe; Valerio Del Bono; Malgorzata Mikulska; Giulia Gustinetti; Anna Marchese; Federica Mina; Alessio Signori; Andrea Orsi; Fulvio Rudello; Cristiano Alicino; Beatrice Bonalumi; Alessandra Morando; Giancarlo Icardi; Sabrina Beltramini; Claudio Viscoli
Journal:  Infection       Date:  2017-08-30       Impact factor: 3.553

4.  A model for predicting nosocomial carbapenem-resistant Klebsiella pneumoniae infection.

Authors:  Duo Yang; Zeqiang Xie; Xuli Xin; Wenying Xue; Man Zhang
Journal:  Biomed Rep       Date:  2016-09-07

Review 5.  Bloodstream infections in internal medicine.

Authors:  Valerio Del Bono; Daniele Roberto Giacobbe
Journal:  Virulence       Date:  2016-01-13       Impact factor: 5.882

Review 6.  Emerging and re-emerging infectious disease in otorhinolaryngology.

Authors:  F Scasso; G Ferrari; G C DE Vincentiis; A Arosio; S Bottero; M Carretti; A Ciardo; S Cocuzza; A Colombo; B Conti; A Cordone; M DE Ciccio; E Delehaye; L Della Vecchia; I DE Macina; C Dentone; P DI Mauro; R Dorati; R Fazio; A Ferrari; G Ferrea; S Giannantonio; I Genta; M Giuliani; D Lucidi; L Maiolino; G Marini; P Marsella; D Meucci; T Modena; B Montemurri; A Odone; S Palma; M L Panatta; M Piemonte; P Pisani; S Pisani; L Prioglio; A Scorpecci; L Scotto DI Santillo; A Serra; C Signorelli; E Sitzia; M L Tropiano; M Trozzi; F M Tucci; L Vezzosi; B Viaggi
Journal:  Acta Otorhinolaryngol Ital       Date:  2018-04       Impact factor: 2.124

7.  Epidemiology and biomolecular characterization of carbapenem-resistant klebsiella pneumoniae in an Italian hospital.

Authors:  M L Cristina; M Sartini; G Ottria; E Schinca; N Cenderello; M P Crisalli; P Fabbri; G Lo Pinto; D Usiglio; A M Spagnolo
Journal:  J Prev Med Hyg       Date:  2016-09

8.  Carbapenem-Resistant Enterobacteriaceae Infections: Results From a Retrospective Series and Implications for the Design of Prospective Clinical Trials.

Authors:  Elizabeth L Alexander; Jeffery Loutit; Mario Tumbarello; Richard Wunderink; Tim Felton; George Daikos; Karen Fusaro; Dan White; Shu Zhang; Michael N Dudley
Journal:  Open Forum Infect Dis       Date:  2017-06-01       Impact factor: 3.835

9.  Double carbapenem as a rescue strategy for the treatment of severe carbapenemase-producing Klebsiella pneumoniae infections: a two-center, matched case-control study.

Authors:  Gennaro De Pascale; Gennaro Martucci; Luca Montini; Giovanna Panarello; Salvatore Lucio Cutuli; Daniele Di Carlo; Valentina Di Gravio; Roberta Di Stefano; Guido Capitanio; Maria Sole Vallecoccia; Piera Polidori; Teresa Spanu; Antonio Arcadipane; Massimo Antonelli
Journal:  Crit Care       Date:  2017-07-05       Impact factor: 9.097

10.  The Rapid Prediction of Carbapenem Resistance in Patients With Klebsiella pneumoniae Bacteremia Using Electronic Medical Record Data.

Authors:  Timothy Sullivan; Osamu Ichikawa; Joel Dudley; Li Li; Judith Aberg
Journal:  Open Forum Infect Dis       Date:  2018-04-28       Impact factor: 3.835

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.